Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
29.65
-1.37 (-4.42%)
At close: May 8, 2026, 4:00 PM EDT
29.25
-0.40 (-1.35%)
Pre-market: May 11, 2026, 8:23 AM EDT
Eton Pharmaceuticals Market Cap
Eton Pharmaceuticals has a market cap or net worth of $811.22 million as of May 11, 2026. Its market cap has increased by 91.57% in one year.
Market Cap
811.22M
Enterprise Value
816.36M
1-Year Change
91.57%
Ranking
Category
Stock Price
$29.65
Market Cap Chart
Since November 13, 2018, Eton Pharmaceuticals's market cap has increased from $105.74M to $811.22M, an increase of 667.18%. That is a compound annual growth rate of 31.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 811.22M | 78.89% |
| Dec 31, 2025 | 453.48M | 27.82% |
| Dec 31, 2024 | 354.78M | 215.68% |
| Dec 29, 2023 | 112.38M | 57.54% |
| Dec 30, 2022 | 71.34M | -32.42% |
| Dec 31, 2021 | 105.56M | -46.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Collegium Pharmaceutical | 1.22B |
| Xeris Biopharma Holdings | 1.13B |
| Evotec SE | 1.08B |
| Alvotech | 1.02B |
| Cronos Group | 953.79M |
| Pacira BioSciences | 910.90M |
| Amphastar Pharmaceuticals | 837.77M |
| Esperion Therapeutics | 808.25M |